| Literature DB >> 35265336 |
Karen Juelsgaard Christiansen1, Louise Devantier2,3, Thomas Pasgaard4, Thea Emily Benson5, Johanne Juel Petersen2, Thomas Kjærgaard6, Michael Pedersen2.
Abstract
Background: Prolonged healing of tracheostomy after decannulation has a negative impact on respiration, hygiene, cosmetics, and social life. Even so, evidence-based observations of tracheostoma healing time are lacking. Therefore, the aim of this study was to determine tracheostomy wound healing time after decannulation.Entities:
Keywords: Tracheostomy; complication; decannulation; healing; prolonged mechanical ventilation; wound closure
Year: 2022 PMID: 35265336 PMCID: PMC8859721 DOI: 10.4081/mrm.2022.822
Source DB: PubMed Journal: Multidiscip Respir Med ISSN: 1828-695X
Correlation coefficients and statistical analysis of potential predictors and healing time of tracheostoma wound among study participants (n=28).
| Determinants of healing time |
| p |
|---|---|---|
| Tracheostomy treatment (days) | 0.41 | 0.03 |
| Sex | - | 0.75 |
| Age (years) | -0.24 | 0.23 |
| Smoking status | - | 0.90 |
| BMI (kg/m2) | 0.08 | 0.68 |
| Downsized tube | - | 0.69 |
| Diabetes | - | 0.85 |
| Chronic obstructive lung disease | - | 0.13 |
| Ischemic heart disease | - | 0.75 |
| In-hospital immunosuppressants | - | 0.69 |
| Bleeding complications | - | 0.62 |
Primary diagnoses and healing time. Data obtained by inspection of ICU patient notes. An overview of patient admission, divided into Medical and Surgical Specialties, Primary Diagnoses, and Tracheostomy Healing Time.Determinants of healing time
| Specialty | Primary diagnosis at the time of admission to the ICU | Healing time (days) |
|---|---|---|
| Cardiology | MI | 16 |
| Cardiology | MI + IMPELLA | 4 |
| Cardiology | MI | 7 |
| Cardiology | MI complicated by VSD | 19 |
| Cardiology | Cardiac arrest | 3 |
| Thoracic surgery | Aorta valve replacement | 4 |
| Thoracic surgery | PTE | 11 |
| Thoracic Surgery | Mitral valve replacement + CABG | 7 |
| Thoracic Surgery | Aortic valve replacement | 2 |
| Thoracic Surgery | Aortic valve replacement + CABG | 9 |
| Thoracic Surgery | Aortic dissection | 16 |
| Thoracic Surgery | Aortic dissection | 17 |
| Thoracic Surgery | Thoracic and abdominal aortic aneurysm | 4 |
| Thoracic Surgery | Trauma sternum + costae fracture | 3 |
| Cardiology/Thoracic Surgery | HTX | 12 |
| Cardiology/Thoracic Surgery | HTX | 4 |
| Cardiology/Thoracic Surgery | HTX | 22 |
| Cardiology/Thoracic Surgery | Heart failure (LVAD) | 15 |
| Cardiology/Thoracic Surgery | HTX | 7 |
| Esophagus Surgery | Esophagus cancer | 1 |
| Esophagus Surgery | Esophagus cancer | 3 |
| Esophagus Surgery | Esophagus perforation | 6 |
| Pulmonary Medicine | Pneumonia (Wegener’s gran.) | 1 |
| Pulmonary Medicine | Pneumonia | 2 |
| Pulmonary Medicine | Respiratory failure (Wegener’s gran.) | 10 |
| Pulmonary Medicine | Pneumonia (Wegener’s gran.) | 6 |
| Infectious Diseases | Odontoid fracture + paravertebral abscess | 11 |
| Infectious Diseases | Pneumococcal meningitis | 5 |
MI, myocardial infarction; IMPELLA, implantation of intracardial assist device; VSD, ventricular septal defect; PTE, pulmonary thromboendarterectomy; CABG, coronary artery bypass grafting; HTX, heart transplantation; LVAD, left ventricular assist device.
Figure 1.Patients with more than one course of tracheostomy tube treatment. Data produced by study investigator through daily patient observation. An overview of patient recannulation and/or oral intubation courses.
Blue line, tracheostomy treatment; grey area, decannulation; green area, time from decannulation to complete stomal closure; purple area, oral intubation; 1 day, intubated and decannulated (vice versa) on the same day. Patient no. 4 was orally intubated for five days (purple); and his time from decannulation to complete stomal closure was 16 days (green).
Patient characteristics (n=28). Data obtained by inspection of ICU patient notes. An overview of factors analyzed for statistical significance in wound healing time.
| Healing time (days), median [range] | 6.5 [1-22] |
|---|---|
| Tracheostomy tube treatment (days), median [range] | 15.5 [4-93] |
| Sex, n (%) | |
| Female | 4(14) |
| Male | 24(86) |
| Age, median [range] | 60.5 [40-89] |
| Smoking status, n (%) | |
| Never | 13(46) |
| Former | 12(43) |
| Current | 3(11) |
| BMI (kg/m2), n (%) | |
| <25 | 9(32) |
| 25-30 | 12(43) |
| >30 | 7(25) |
| Initial tube size, n (%) | |
| 7 mm | 2(7) |
| 8 mm | 26(93) |
| Downsized tube, n (%) | |
| No | 11(39) |
| Yes | 17(61) |
| Diabetes, n (%) | |
| No | 20(71) |
| Yes | 8(29) |
| COPD, n (%) | |
| No | 23(82) |
| Yes | 5(18) |
| Ischemic heart disease, n (%) | |
| No | 28(64) |
| Yes | 10(36) |
| In-hospital immunosuppressants, n (%) | |
| No | 20(71) |
| Yes | 8(29) |
| Bleeding complications, n (%) | |
| No | 23(82) |
| Yes | 5(18) |
BMI, body mass index; COPD, chronic obstructive pulmonary disease.